Contact Us
Pay Invoice
Follow Us!
Latest Blogs
- Latest CDC Findings: A Wake‑Up Call for the $1.3 Billion Global Sepsis Diagnostics Market April 6, 2026
- NAMs, NIH Policy, and What it Means for Diagnostics March 20, 2026
- As Flu Outpaces COVID This Winter, Rapid Molecular Testing Takes on New Importance March 17, 2026
- March Is Colorectal Cancer Awareness Month: How Liquid Biopsy Is Shaping the Future of CRC Detection and Care February 20, 2026
- Global IVD Growth: Stability, Shifting Markets, and the Road to 2030 February 11, 2026
Sitemap
Your Data and Privacy
About Us
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.
Visit Science and Medicine Group
Visit Science and Medicine Group
Data-Driven Insights into the Microbiome Landscape
The microbiome is a rapidly growing market. Understanding the detailed roles and functions of the microbiome is important as it is linked to a multitude of critical areas from human health to environmental sustainability. (A recent report on “Analytics of the Microbiome” by Arogyam covers all aspects of the microbiome landscape. A free preview of the […]
CRISPR: Saving the World or Playing with Dynamite?
It’s an oft-told story that the fortune of Swedish chemist and businessman Alfred Nobel was founded on patented explosives, including dynamite. While his products were used beneficially in mining and construction applications, their wartime use in munitions gave him concern that he would be remembered solely as a ‘merchant of death’. Consequently, Nobel set aside […]
Lab-Developed Test Market Exceeds 12 Billion: What You Need to Know
What is a Lab-Developed Test? In vitro diagnostic (IVD) tests are manufactured and sold by diagnostic companies following approval (or clearance) by the appropriate regulatory agencies. IVD tests are then distributed and used by many different clinical laboratories. In contrast, a laboratory developed test (LDTs) is developed by a clinical laboratory for use specifically in […]
Urgent Care – Growth, But Also Increasing Competition and Possible Saturation
Urgent care’s story in the United States has been all about growth. They offer walk-in care and a range of services, expanded hours and limited wait times. They usually have imaging equipment and multiple providers and are in a freestanding location or a dedicated store within a retail strip mall. With approximately 10,000 locations across […]
Microbiome Applications in IVD
It’s beyond theory. The microbiome is one of many trends that align well with the IVD market. It is explored in Kalorama Information’s study of the in vitro diagnostic market, The Worldwide Market for In Vitro Diagnostic Tests along with other trends such as automation and gene editing. The continuous search of the etiology of […]
Diagnostics Market to Exceed 80 Billion Dollars in 2020 as Volume of COVID-19 Testing Continues
The world market for in vitro diagnostics will reach 83.3 billion dollars in 2020, when the molecular and antibody sales of COVID-19 testing is considered. This is according to our latest report, The Worldwide Market for In Vitro Diagnostics, 13th Edition, due out August 26th. Molecular diagnostics, for the first time in Kalorama Information’s two-decade […]
COVID-19 Is Positive and Negative for Digital Pathology
Our latest report finds that digital pathology market is 710 million in 2020. The COVID-19 pandemic, while disrupting healthcare in general, also provides a selling point as many pathologists are now at home and need to work digitally. Kalorama Information’s recent study Digital Pathology Markets, 2020-2025, finds a vibrant market that is pushed by the […]
Thermo and Qiagen Merger Changes Molecular Diagnostics
As Kalorama publishes its latest update in molecular diagnostics, finding a 13 billion-dollar market, a major merger is set to change things. Here’s what to expect. The market picture for molecular diagnostics had remained stable over the years. While there are scores of molecular diagnostic companies, and an explosion of PCR test kit companies during […]
COVID-19 Testing Increases Value of Global Molecular Diagnostics Market
As the COVID-19 crisis surfaced in the United States, molecular diagnostic manufacturers went to work with new RT-PCR testing kits. The worldwide demand for COVID tests has materialized rapidly from zero and already on course become a 1.3 billion-dollar market in the first half of 2020. There have been hundreds of tests on the market […]
Could COVID-19 Influence LDT Regulation?
Lab-developed tests were controversial before the COVID-19 pandemic, and there was attempts at regulating them more in the United States. Then came a massive infectious disease threat for which lab developed tests were essential. The sudden onset of a disease for which there were no existing test products, so labs had to develop their own. […]